We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
(+13%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7
years
Top 10 Avg Time Held Equity + Options
2.9
years
Top 20 Avg Time Held Equity + Options
3.8
years
Avg Time Held Equity only
4.7
years
Top 10 Avg Time Held Equity only
2.9
years
Top 20 Avg Time Held Equity only
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$18.4M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$9.77M |
| 3 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$5.48M |
| 4 |
Microsoft
MSFT
|
+$4.93M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$4.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$7.34M |
| 2 |
Starbucks
SBUX
|
+$4.7M |
| 3 |
iShares California Muni Bond ETF
CMF
|
+$3.3M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.63M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 17.21% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2901
MaxLinear
MXL
$6.5B
| $2.88K | ﹤0.01% |
203
+147
| +263% | +$1.7K |
2024 Q4
2 quarters
|
|
2902
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.95B
| $2.88K | ﹤0.01% |
103
-153
| -60% | -$4.1K |
2023 Q4
6 quarters
|
|
2903
Crescent Energy
CRGY
$5.58B
| $2.88K | ﹤0.01% |
335
-138
| -29% | -$1.21K |
2023 Q1
9 quarters
|
|
2904
Embecta
EMBC
$359M
| $2.88K | ﹤0.01% |
297
+86
| +41% | +$967 |
2022 Q2
12 quarters
|
|
2905
Vanguard US Quality Factor ETF
VFQY
$507M
| $2.87K | ﹤0.01% |
20
| – | – |
2022 Q2
12 quarters
|
|
2906
Grid Dynamics Holdings
GDYN
$632M
| $2.86K | ﹤0.01% |
248
+10
| +4% | +$132 |
2023 Q3
7 quarters
|
|
2907
Global X Data Center & Digital Infrastructure ETF
DTCR
$1.94B
| $2.85K | ﹤0.01% |
153
-5,128
| -97% | -$87.3K |
2024 Q2
4 quarters
|
|
2908
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.99B
| $2.85K | ﹤0.01% |
+68
| New | +$2.81K |
2025 Q2
0 quarters
|
|
2909
Range Nuclear Renaissance Index ETF
NUKZ
$655M
| $2.83K | ﹤0.01% |
50
-2,000
| -98% | -$92K |
2025 Q1
1 quarter
|
|
2910
Center Bancorp
CNOB
$1.53B
| $2.83K | ﹤0.01% |
122
-152
| -55% | -$3.47K |
2022 Q4
10 quarters
|
|
2911
StoneX
SNEX
$6.84B
| $2.83K | ﹤0.01% |
70
+41
| +141% | +$1.54K |
2024 Q2
4 quarters
|
|
2912
Cohen & Steers Infrastructure Fund
UTF
$2.86B
| $2.82K | ﹤0.01% |
104
| – | – |
2017 Q1
33 quarters
|
|
2913
Dauch Corp
DCH
$1.18B
| $2.8K | ﹤0.01% |
687
-468
| -41% | -$1.89K |
2025 Q1
1 quarter
|
|
2914
Copa Holdings
CPA
$5.41B
| $2.8K | ﹤0.01% |
25
-4
| -14% | -$395 |
2020 Q2
20 quarters
|
|
2915
Getty Realty Corp
GTY
$1.75B
| $2.76K | ﹤0.01% |
100
-58
| -37% | -$1.66K |
2024 Q2
4 quarters
|
|
2916
MicroSectors FANG+ Index 2X Leveraged ETNs due 8 Jan 2038
FNGO
$755M
| $2.76K | ﹤0.01% |
+25
| New | +$2.12K |
2025 Q2
0 quarters
|
|
2917
Construction Partners
ROAD
$4.72B
| $2.76K | ﹤0.01% |
26
+12
| +86% | +$1.12K |
2024 Q4
2 quarters
|
|
2918
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.67B
| $2.75K | ﹤0.01% |
74
-25
| -25% | -$858 |
2022 Q2
12 quarters
|
|
2919
ePlus
PLUS
$2.47B
| $2.74K | ﹤0.01% |
38
-3
| -7% | -$197 |
2020 Q4
18 quarters
|
|
2920
Oxford Industries
OXM
$398M
| $2.74K | ﹤0.01% |
68
-219
| -76% | -$11K |
2025 Q1
1 quarter
|
|
2921
Bumble
BMBL
$783M
| $2.73K | ﹤0.01% |
414
+222
| +116% | +$1.12K |
2021 Q1
17 quarters
|
|
2922
Mativ Holdings
MATV
$620M
| $2.72K | ﹤0.01% |
399
+233
| +140% | +$1.34K |
2025 Q1
1 quarter
|
|
2923
DELISTED
Kennedy-Wilson Holdings
KW
| $2.71K | ﹤0.01% |
399
-456
| -53% | -$3.04K |
2021 Q1
17 quarters
|
|
2924
Neogen
NEOG
$2.58B
| $2.71K | ﹤0.01% |
567
-760
| -57% | -$4.36K |
2016 Q4
34 quarters
|
|
2925
First Trust Dividend Strength ETF
FTDS
$39.2M
| $2.71K | ﹤0.01% |
52
| – | – |
2023 Q4
6 quarters
|
|
Similar funds
Parallel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
- Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
- Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
- Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
- Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
- Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.
Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.